CSL slashes 15% of workforce and offshoots vaccine division
Australia’s largest pharmaceutical company CSL will reduce its headcount by 15% and spin off its vaccine division in response to…
Trump Tariffs
-
-
Podcast: US tariff news and Q2 earnings influence pharma trends
After months of negotiations, the EU and US reached an agreement to levy a 15% tariff on EU imports, which…
-
US-China tensions offer new opportunity for APAC biotechs, report suggests
Investors are increasingly focused on biotech companies outside of China operating in the Asia-Pacific (APAC) market, according to a report…
-
New US-EU trade deal on tariffs ends pharma’s geopolitical immunity
For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation between the…
-
Pharma CEOs downplay impact of tariffs amid rising cost concerns
Despite analyst warnings of heightened financial risk, pharma CEOs across the US and Europe remain confident that the latest US-EU…
-
Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition
In a bid to boost its presence in the lucrative biosimilar space, Sandoz has signed a non-binding agreement to buy…
-
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing
Pharmaceutical companies and manufacturers, including MilliporeSigma (Burlington, US), Simtra BioPharma Solutions (Parsippany, US), Carbogen AMCIS (Bubendorf, Switzerland), and BioNTech (Mainz,…
-
Trump’s 200% tariff threat could send shockwaves through pharma supply chains
US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through global supply…
-
Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade
India and the US are on the verge of a trade agreement that will transform commerce between the two largest…
-
Can pharma tariffs “Make America Manufacture Again”?
As President Trump continues to signal import tariffs on pharmaceuticals to bolster US manufacturing, experts warn this could hike costs…
